FSB Premier Wealth Management’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
FSB Premier Wealth Management's NVS Position: Q1 2026 in Review
FSB Premier Wealth Management reduced its Novartis (NVS) stake by 1.4% in Q1 2026, selling an estimated $38.2K and leaving 16,970 shares worth $2.59M. The position accounts for 0.81% of the portfolio, ranked #33.
FSB Premier Wealth Management first reported a position in NVS in Q4 2021 and has held it in 15 quarters since. 1,591 funds tracked by Wall St. Rank hold NVS as of Q1 2026.
- FSB Premier Wealth Management held 16,970 shares of Novartis worth $2.59M as of Q1 2026.
- FSB Premier Wealth Management sold 249 Novartis shares in Q1 2026, an estimated $38.2K.
- Novartis made up 0.81% of FSB Premier Wealth Management's portfolio in Q1 2026, its #33 holding.
- FSB Premier Wealth Management first reported a position in Novartis in Q4 2021 and has held it in 15 quarters since.
- 1,591 funds tracked by Wall St. Rank held Novartis as of Q1 2026.
Based on FSB Premier Wealth Management's 13F filing for Q1 2026, filed 13 May 2026.